Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

INVO Fertility (IVF) Gross Profit (2016 - 2025)

INVO Fertility has reported Gross Profit over the past 15 years, most recently at $629345.0 for Q3 2025.

  • Quarterly Gross Profit rose 41.53% to $629345.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2025, up 0.76% year-over-year, with the annual reading at $2.8 million for FY2024, 159.15% up from the prior year.
  • Gross Profit was $629345.0 for Q3 2025 at INVO Fertility, down from $770051.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $3.0 million in Q4 2021 and troughed at $67883.0 in Q2 2022.
  • The 5-year median for Gross Profit is $444686.0 (2024), against an average of $555617.5.
  • Year-over-year, Gross Profit surged 1510.18% in 2021 and then crashed 93.37% in 2022.
  • A 5-year view of Gross Profit shows it stood at $3.0 million in 2021, then crashed by 93.37% to $198948.0 in 2022, then skyrocketed by 148.81% to $495004.0 in 2023, then soared by 35.16% to $669068.0 in 2024, then fell by 5.94% to $629345.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Gross Profit are $629345.0 (Q3 2025), $770051.0 (Q2 2025), and $592256.0 (Q1 2025).